Universe Pharma (UPC) - צמיחת רווח למניה בשנה הנוכחית

The current YoY EPS growth rate demonstrates the resilience of Universe Pharmaceuticals (UPC), as demand for medications remains independent of economic cycles. Profit stability is based on the production of masks and Chinese pharmaceuticals. Revenues rely on integration into the logistics of PRC hospitals, although government regulation limits margins. Currently, this metric stands at 0.00, which captures the annual dynamics of the business's profitability.

Investors are assessing the potential of Universe Pharmaceuticals (UPC) through the dynamics of earnings per share. This ratio measures the percentage deviation of the current EPS from the previous year's value, reflecting the efficiency of the pharmacy network modernization and the R&D pipeline. The current value of 0.00, recorded as the annual EPS change ratio, confirms the business's moderate market adaptation, determining the company's degree of resilience to financial risks.